Intervention Protocol

You have free access to this content

Allogeneic stem cell transplantation with matched sibling donor versus autologous stem cell transplantation for newly diagnosed Multiple Myeloma

  1. Ya Tan,
  2. ShuangNian Xu,
  3. Xi Li,
  4. JiePing Chen*

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 30 APR 2013

DOI: 10.1002/14651858.CD010484


How to Cite

Tan Y, Xu S, Li X, Chen J. Allogeneic stem cell transplantation with matched sibling donor versus autologous stem cell transplantation for newly diagnosed Multiple Myeloma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010484. DOI: 10.1002/14651858.CD010484.

Author Information

  1. Southwest Hospital, Third Military Medical University, Center for Hematology, Chongqing, China

*JiePing Chen, Center for Hematology, Southwest Hospital, Third Military Medical University, 38 Gao Tanyan Street, Chongqing, 400038, China. chenjpxn@yahoo.com.cn.

Publication History

  1. Publication Status: New
  2. Published Online: 30 APR 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effects of the use of autologous stem cell transplantation (ASCT), which includes single ASCT and tandem ASCT, versus allogeneic stem cell transplantation (alloSCT) from a matched sibling donor, which includes single alloSCT, non-myeloablative alloSCT and ASCT-alloSCT, in patients with multiple myeloma (MM).